BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 24975674)

  • 1. Overexpression of p300 correlates with poor prognosis in patients with cutaneous squamous cell carcinoma.
    Chen MK; Cai MY; Luo RZ; Tian X; Liao QM; Zhang XY; Han JD
    Br J Dermatol; 2015 Jan; 172(1):111-9. PubMed ID: 24975674
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Expression Status and Prognostic Value of Cancer Stem Cell Biomarker CD133 in Cutaneous Squamous Cell Carcinoma.
    Xu R; Cai MY; Luo RZ; Tian X; Han JD; Chen MK
    JAMA Dermatol; 2016 Mar; 152(3):305-11. PubMed ID: 26560495
    [TBL] [Abstract][Full Text] [Related]  

  • 3. High expression of transcriptional coactivator p300 correlates with aggressive features and poor prognosis of hepatocellular carcinoma.
    Li M; Luo RZ; Chen JW; Cao Y; Lu JB; He JH; Wu QL; Cai MY
    J Transl Med; 2011 Jan; 9():5. PubMed ID: 21205329
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tumor programmed cell death ligand 1 expression correlates with nodal metastasis in patients with cutaneous squamous cell carcinoma of the head and neck.
    García-Pedrero JM; Martínez-Camblor P; Diaz-Coto S; Munguia-Calzada P; Vallina-Alvarez A; Vazquez-Lopez F; Rodrigo JP; Santos-Juanes J
    J Am Acad Dermatol; 2017 Sep; 77(3):527-533. PubMed ID: 28716437
    [TBL] [Abstract][Full Text] [Related]  

  • 5. High expression levels of COX-2 and P300 are associated with unfavorable survival in laryngeal squamous cell carcinoma.
    Chen YF; Luo RZ; Li Y; Cui BK; Song M; Yang AK; Chen WK
    Eur Arch Otorhinolaryngol; 2013 Mar; 270(3):1009-17. PubMed ID: 23179937
    [TBL] [Abstract][Full Text] [Related]  

  • 6. High expression of the transcriptional co-activator p300 predicts poor survival in resectable non-small cell lung cancers.
    Hou X; Li Y; Luo RZ; Fu JH; He JH; Zhang LJ; Yang HX
    Eur J Surg Oncol; 2012 Jun; 38(6):523-30. PubMed ID: 22440742
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Decreased expression of microRNA-20a promotes tumor progression and predicts poor prognosis of cutaneous squamous cell carcinoma.
    Zhang L; Xiang P; Han X; Wu L; Li X; Xiong Z
    Int J Clin Exp Pathol; 2015; 8(9):11446-51. PubMed ID: 26617873
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Elevated expression of T-lymphoma invasion and metastasis inducing factor 1 in squamous-cell carcinoma of the head and neck and its clinical significance.
    Wang S; Li S; Yang X; Yang S; Liu S; Liu B; Liu J
    Eur J Cancer; 2014 Jan; 50(2):379-87. PubMed ID: 24189000
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lymph node metastases from cutaneous squamous cell carcinoma of the head and neck.
    Moore BA; Weber RS; Prieto V; El-Naggar A; Holsinger FC; Zhou X; Lee JJ; Lippman S; Clayman GL
    Laryngoscope; 2005 Sep; 115(9):1561-7. PubMed ID: 16148695
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Head and neck cutaneous squamous cell carcinoma requiring parotidectomy: prognostic indicators and treatment selection.
    Sweeny L; Zimmerman T; Carroll WR; Schmalbach CE; Day KE; Rosenthal EL
    Otolaryngol Head Neck Surg; 2014 Apr; 150(4):610-7. PubMed ID: 24474713
    [TBL] [Abstract][Full Text] [Related]  

  • 11. High TMPRSS4 expression is a predictor of poor prognosis in cervical squamous cell carcinoma.
    Cheng D; Liang B; Li Y
    Cancer Epidemiol; 2013 Dec; 37(6):993-7. PubMed ID: 24012692
    [TBL] [Abstract][Full Text] [Related]  

  • 12. An evolving paradigm for the workup and management of high-risk cutaneous squamous cell carcinoma.
    O'Bryan K; Sherman W; Niedt GW; Taback B; Manolidis S; Wang A; Ratner D
    J Am Acad Dermatol; 2013 Oct; 69(4):595-602.e1. PubMed ID: 23871719
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Putative stem cell markers in cervical squamous cell carcinoma are correlated with poor clinical outcome.
    Hou T; Zhang W; Tong C; Kazobinka G; Huang X; Huang Y; Zhang Y
    BMC Cancer; 2015 Oct; 15():785. PubMed ID: 26499463
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The expression of activin receptor-like kinase 1 among patients with head and neck cancer.
    Chien CY; Chuang HC; Chen CH; Fang FM; Chen WC; Huang CC; Huang HY
    Otolaryngol Head Neck Surg; 2013 Jun; 148(6):965-73. PubMed ID: 23447486
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Low-Level Expression of p-S6 Is Associated with Nodal Metastasis in Patients with Head and Neck Cutaneous Squamous Cell Carcinoma.
    Gómez-de Castro C; Santos-Juanes R; Nuñez-Gómez B; Fernández-Vega I; Vivanco B; Fernández-Velasco A; Reyes-García S; Carrero-Martín J; García-Pedrero JM; Rodrigo JP; González-Vela MDC; Santos-Juanes J; Galache C
    Int J Mol Sci; 2024 Apr; 25(8):. PubMed ID: 38673889
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Epidermal growth factor receptor expression is associated with poor outcome in cutaneous squamous cell carcinoma.
    Cañueto J; Cardeñoso E; García JL; Santos-Briz Á; Castellanos-Martín A; Fernández-López E; Blanco Gómez A; Pérez-Losada J; Román-Curto C
    Br J Dermatol; 2017 May; 176(5):1279-1287. PubMed ID: 27510450
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Is immunohistochemical epidermal growth factor receptor expression overestimated as a prognostic factor in head-neck squamous cell carcinoma? A retrospective analysis based on a tissue microarray of 365 carcinomas.
    Fischer C; Zlobec I; Stöckli E; Probst S; Storck C; Tornillo L; Lugli A; Wolfensberger M; Terracciano L
    Hum Pathol; 2008 Oct; 39(10):1527-34. PubMed ID: 18620726
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Podoplanin expression in cutaneous head and neck squamous cell carcinoma--prognostic value and clinicopathologic implications.
    Kreppel M; Krakowezki A; Kreppel B; Drebber U; Wedemeyer I; Mauch C; Zöller JE; Scheer M
    J Surg Oncol; 2013 Mar; 107(4):376-83. PubMed ID: 22886751
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Epidermal growth factor receptor: a novel biomarker for aggressive head and neck cutaneous squamous cell carcinoma.
    Ch'ng S; Low I; Ng D; Brasch H; Sullivan M; Davis P; Tan ST
    Hum Pathol; 2008 Mar; 39(3):344-9. PubMed ID: 18045646
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Myosin18B predicts favorable prognosis of cutaneous squamous-cell carcinoma.
    Cao C; Zhang C; Sun Y; Mu Z; Shen Q
    Genes Genomics; 2021 Apr; 43(4):371-378. PubMed ID: 33555505
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.